blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0885004

EP0885004 - USE OF 4-PHENYL-3,6-DIHYDRO-2H-PYRIDYL DERIVATIVES AS NMDA RECEPTOR SUBTYPE BLOCKERS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.03.2003
Database last updated on 06.07.2024
Most recent event   Tooltip07.03.2003No opposition filed within time limitpublished on 23.04.2003  [2003/17]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [1998/52]For all designated states
F.HOFFMANN-LA ROCHE AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / BOURSON, Anne
Résidence Mont-des-Roses 6, rue du Réservoir
F-68100 Mulhouse / FR
02 / FISCHER, Günther
Bühlstrasse 48
D-79541 Lörrach / DE
03 / HEITZ NEIDHART, Marie-Paule
9, rue du Steinler
F-68220 Hagenthal-le-Bas / FR
04 / MUTEL, Vincent
15, place des Maréchaux
F-68100 Mulhouse / FR
05 / TRUBE, Gerhard
Langentalstrasse 41
D-79618 Rheinfelden / DE
[1998/52]
Representative(s)Poppe, Regina
F.Hoffmann-La Roche AG
Patent Department(PLP)
124 Grenzacherstrasse
4070 Basel / CH
[N/P]
Former [1998/52]Poppe, Regina
F.Hoffmann-La Roche AG Patent Department(PLP), 124 Grenzacherstrasse
4070 Basel / CH
Application number, filing date97905107.527.02.1997
[1998/52]
WO1997EP00951
Priority number, dateEP1996010363608.03.1996         Original published format: EP 96103636
[1998/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9732581
Date:12.09.1997
Language:EN
[1997/39]
Type: A1 Application with search report 
No.:EP0885004
Date:23.12.1998
Language:EN
The application published by WIPO in one of the EPO official languages on 12.09.1997 takes the place of the publication of the European patent application.
[1998/52]
Type: B1 Patent specification 
No.:EP0885004
Date:02.05.2002
Language:EN
[2002/18]
Search report(s)International search report - published on:EP12.09.1997
ClassificationIPC:A61K31/4418, A61P25/28, A61P25/14, A61P25/16, A61P9/10
[2001/22]
CPC:
A61K31/4418 (EP,US); A61K31/44 (KR); A61P25/00 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/28 (EP);
A61P43/00 (EP); A61P9/10 (EP) (-)
Former IPC [1998/52]A61K31/44
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1998/52]
TitleGerman:VERWENDUNG VON 4-PHENYL-3,6-DIHYDRO-2H-PYRIDYL DERIVATEN ALS NMDA REZEPTOR SUBTYP BLOCKER[1998/52]
English:USE OF 4-PHENYL-3,6-DIHYDRO-2H-PYRIDYL DERIVATIVES AS NMDA RECEPTOR SUBTYPE BLOCKERS[1998/52]
French:UTILISATION DE DERIVES DE 4-PHENYL-3,6-DIHYDRO-2H-PYRIDILE COMME AGENTS BLOQUANTS DES SOUS-TYPES DES RECEPTEURS NMDA[1998/52]
Entry into regional phase01.09.1998National basic fee paid 
01.09.1998Designation fee(s) paid 
01.09.1998Examination fee paid 
Examination procedure16.09.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
01.09.1998Examination requested  [1998/52]
11.10.1999Despatch of a communication from the examining division (Time limit: M04)
04.02.2000Reply to a communication from the examining division
25.07.2000Despatch of a communication from the examining division (Time limit: M06)
08.01.2001Reply to a communication from the examining division
02.05.2001Despatch of communication of intention to grant (Approval: Yes)
08.08.2001Communication of intention to grant the patent
18.10.2001Fee for grant paid
18.10.2001Fee for publishing/printing paid
Opposition(s)04.02.2003No opposition filed within time limit [2003/17]
Fees paidRenewal fee
10.02.1999Renewal fee patent year 03
11.02.2000Renewal fee patent year 04
15.02.2001Renewal fee patent year 05
13.02.2002Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DX]DE1964421  (HOFFMANN LA ROCHE) [DX] 1,3-5 * the whole document *;
 [X]DE2128836  (HOFFMANN-LA ROCHE) [X] 3 * page 5, paragraph L; example 5; claim - *;
 [DX]US3723445  (EDENHOFER A, et al) [DX] 1,3-5 * column W *;
 [A]EP0445701  (SHIONOGI & CO [JP]) [A] 1-5 * abstract * * page 2, line 16 - line 19; examples 109-111; claim - *;
 [X]DE4325855  (BOEHRINGER INGELHEIM KG [DE]) [X] 1,4,5 * abstract * * page 3, line 52 - line 55; example -; claim - *;
 [PA]WO9641629  (HOFFMANN LA ROCHE [CH]) [PA] 1-5* the whole document *;
 [A]  - P. KLEPSTAD ET AL., "Evidence of a role for NMDA receptors in pain perception", EUROPEAN JOURNAL OF PHARMACOLOGY, (1990), vol. 187, no. 3, pages 513 - 518, XP000675249 [A] 1,3-5 * the whole document *

DOI:   http://dx.doi.org/10.1016/0014-2999(90)90379-K
 [X]  - J.C. JAEN ET AL., "Dopamine autoreceptor agonists as potential antipsychotics", JOURNAL OF MEDICINAL CHEMISTRY, (1988), vol. 31, no. 8, pages 1621 - 1625, XP000674393 [X] 1,4,5 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm00403a022
 [A]  - J.R. VENDER ET AL., "NMDA receptors: the first decade", EXPERT OPINION ON INVESTIGATIONAL DRUGS, (1994), vol. 3, no. 4, pages 341 - 354, XP002032808 [A] 1-5 * page 348 - page 349 *
 [A]  - S.P. GUPTA ET AL., "Synthesis & structure activity relationship in 3-(o-, m- & p-nitro/amino/acetamido/methanesulphonamido)-phenoxy-2-hidroxy-I-t-aminopropanes - A class of CNS depressants & hipotensive agents", INDIAN JOURNAL OF CHEMISTRY, NEW DELHI, IN, (19770501), vol. 15B, no. 5, pages 466 - 472, XP000675209 [A] 1-5 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.